Poltavets et al., 2020 - Google Patents
Macrophage modification strategies for efficient cell therapyPoltavets et al., 2020
View HTML- Document ID
- 6351979786272411646
- Author
- Poltavets A
- Vishnyakova P
- Elchaninov A
- Sukhikh G
- Fatkhudinov T
- Publication year
- Publication venue
- Cells
External Links
Snippet
Macrophages, important cells of innate immunity, are known for their phagocytic activity, capability for antigen presentation, and flexible phenotypes. Macrophages are found in all tissues and therefore represent an attractive therapeutic target for the treatment of diseases …
- 210000002540 Macrophages 0 title abstract description 244
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Poltavets et al. | Macrophage modification strategies for efficient cell therapy | |
| Di Conza et al. | ER stress responses: an emerging modulator for innate immunity | |
| Conciatori et al. | Role of mTOR signaling in tumor microenvironment: an overview | |
| Paulson et al. | Stress erythropoiesis is a key inflammatory response | |
| Rhee et al. | Mesenchymal stem cell-mediated effects of tumor support or suppression | |
| Fernández-Francos et al. | Mesenchymal stem cell-based therapy as an alternative to the treatment of acute respiratory distress syndrome: current evidence and future perspectives | |
| Uchida et al. | Screening of mRNA chemical modification to maximize protein expression with reduced immunogenicity | |
| Shaik Fakiruddin et al. | Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour | |
| Hillers-Ziemer et al. | Obesity promotes cooperation of cancer stem-like cells and macrophages to enhance mammary tumor angiogenesis | |
| Ueno et al. | Pleiotropic effects of exosomes as a therapy for stroke recovery | |
| Poncin et al. | Immunity and breast cancer: focus on eosinophils | |
| Fiani et al. | Exploiting manipulated small extracellular vesicles to subvert immunosuppression at the tumor microenvironment through mannose receptor/CD206 targeting | |
| Hassan et al. | Hematopoietic cells derived from cancer stem cells generated from mouse induced pluripotent stem cells | |
| Levy et al. | RNA-seq analysis reveals CCR5 as a key target for CRISPR gene editing to regulate in vivo NK cell trafficking | |
| Ferreira et al. | Cell cycle regulation in macrophages and susceptibility to HIV-1 | |
| Hu et al. | Biophysical properties and motility of human mature dendritic cells deteriorated by vascular endothelial growth factor through cytoskeleton remodeling | |
| Lattanzi et al. | Basic and preclinical research for personalized medicine | |
| Chang et al. | Exosomes derived from hypoxia-cultured human adipose stem cells alleviate articular chondrocyte inflammaging and post-traumatic osteoarthritis progression | |
| Bauvois et al. | Activation of interferon signaling in chronic lymphocytic leukemia cells contributes to apoptosis resistance via a JAK-Src/STAT3/Mcl-1 signaling pathway | |
| Lynch et al. | Immune dysfunction, cytokine disruption, and stromal changes in myelodysplastic syndrome: A review | |
| Andreucci et al. | Extracellular lactic acidosis of the tumor microenvironment drives adipocyte-to-myofibroblast transition fueling the generation of cancer-associated fibroblasts | |
| Han et al. | Dual CXCR4/IL-10 gene-edited human amniotic mesenchymal stem cells exhibit robust therapeutic properties in chronic wound healing | |
| Curci et al. | Adult renal stem/progenitor cells can modulate T regulatory cells and double negative T cells | |
| Pötschke et al. | MSI1 promotes the expression of the GBM stem cell marker CD44 by impairing miRNA-dependent degradation | |
| Saenz-Antoñanzas et al. | CRISPR/Cas9 deletion of SOX2 regulatory region 2 (SRR2) decreases SOX2 malignant activity in glioblastoma |